日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Retraction Note: Antibodies against endogenous retroviruses promote lung cancer immunotherapy

撤稿声明:针对内源性逆转录病毒的抗体可促进肺癌免疫疗法

Ng, Kevin W; Boumelha, Jesse; Enfield, Katey S S; Almagro, Jorge; Cha, Hongui; Pich, Oriol; Karasaki, Takahiro; Moore, David A; Salgado, Roberto; Sivakumar, Monica; Young, George; Molina-Arcas, Miriam; de Carné Trécesson, Sophie; Anastasiou, Panayiotis; Fendler, Annika; Au, Lewis; Shepherd, Scott T C; Martínez-Ruiz, Carlos; Puttick, Clare; Black, James R M; Watkins, Thomas B K; Kim, Hyemin; Shim, Seohee; Faulkner, Nikhil; Attig, Jan; Veeriah, Selvaraju; Magno, Neil; Ward, Sophia; Frankell, Alexander M; Al Bakir, Maise; Lim, Emilia L; Hill, Mark S; Wilson, Gareth A; Cook, Daniel E; Birkbak, Nicolai J; Behrens, Axel; Yousaf, Nadia; Popat, Sanjay; Hackshaw, Allan; Hiley, Crispin T; Litchfield, Kevin; McGranahan, Nicholas; Jamal-Hanjani, Mariam; Larkin, James; Lee, Se-Hoon; Turajlic, Samra; Swanton, Charles; Downward, Julian; Kassiotis, George

Combining RAS(ON) G12C-selective inhibitor with SHP2 inhibition sensitises lung tumours to immune checkpoint blockade

将 RAS(ON) G12C 选择性抑制剂与 SHP2 抑制剂相结合可增强肺癌对免疫检查点阻断的敏感性

Panayiotis Anastasiou, Christopher Moore, Sareena Rana, Mona Tomaschko, Claire E Pillsbury, Andrea de Castro, Jesse Boumelha, Edurne Mugarza, Sophie de Carné Trécesson, Ania Mikolajczak, Cristina Blaj, Robert Goldstone, Jacqueline A M Smith, Elsa Quintana, Miriam Molina-Arcas, Julian Downward

Combining RAS(ON) G12C-selective inhibitor with SHP2 inhibition sensitises lung tumours to immune checkpoint blockade

RAS(ON) G12C选择性抑制剂与SHP2抑制剂联合使用可增强肺肿瘤对免疫检查点阻断疗法的敏感性。

Panayiotis Anastasiou,Christopher Moore,Sareena Rana,Mona Tomaschko,Claire E Pillsbury,Andrea de Castro,Jesse Boumelha,Edurne Mugarza,Sophie de Carné Trécesson,Ania Mikolajczak,Cristina Blaj,Robert Goldstone,Jacqueline A M Smith,Elsa Quintana,Miriam Molina-Arcas,Julian Downward

CRISPR-Cas9 Screening Identifies KRAS-Induced COX2 as a Driver of Immunotherapy Resistance in Lung Cancer

CRISPR-Cas9 筛查确定 KRAS 诱导的 COX2 是肺癌免疫疗法耐药性的驱动因素

Jesse Boumelha, Andrea de Castro, Nourdine Bah, Hongui Cha, Sophie de Carné Trécesson, Sareena Rana, Mona Tomaschko, Panayiotis Anastasiou, Edurne Mugarza, Christopher Moore, Robert Goldstone, Phil East, Kevin Litchfield, Se-Hoon Lee, Miriam Molina-Arcas, Julian Downward

CRISPR-Cas9 Screening Identifies KRAS-Induced COX2 as a Driver of Immunotherapy Resistance in Lung Cancer

CRISPR-Cas9筛选发现KRAS诱导的COX2是肺癌免疫治疗耐药性的驱动因素

Jesse Boumelha,Andrea de Castro,Nourdine Bah,Hongui Cha,Sophie de Carné Trécesson,Sareena Rana,Mona Tomaschko,Panayiotis Anastasiou,Edurne Mugarza,Christopher Moore,Robert Goldstone,Phil East,Kevin Litchfield,Se-Hoon Lee,Miriam Molina-Arcas,Julian Downward

Antibodies against endogenous retroviruses promote lung cancer immunotherapy

抗内源性逆转录病毒抗体促进肺癌免疫治疗

Kevin W Ng #, Jesse Boumelha #, Katey S S Enfield #, Jorge Almagro, Hongui Cha, Oriol Pich, Takahiro Karasaki, David A Moore, Roberto Salgado, Monica Sivakumar, George Young, Miriam Molina-Arcas, Sophie de Carné Trécesson, Panayiotis Anastasiou, Annika Fendler, Lewis Au, Scott T C Shepherd, Carlos M

Facts and Hopes on RAS Inhibitors and Cancer Immunotherapy

RAS抑制剂与癌症免疫疗法的现状与展望

Boumelha, Jesse; Molina-Arcas, Miriam; Downward, Julian

Characterisation of a cyclic peptide that binds to the RAS binding domain of phosphoinositide 3-kinase p110α

与磷酸肌醇 3-激酶 p110α 的 RAS 结合域结合的环肽的表征

Mohamed Ismail, Stephen R Martin, Roger George, Francesca Houghton, Geoff Kelly, Raphaël A G Chaleil, Panayiotis Anastasiou, Xinyue Wang, Nicola O'Reilly, Stefania Federico, Dhira Joshi, Hemavathi Nagaraj, Rachel Cooley, Ning Sze Hui, Miriam Molina-Arcas, David C Hancock, Ali Tavassoli, Julian Downw

Therapeutic KRASG12C inhibition drives effective interferon-mediated antitumor immunity in immunogenic lung cancers

治疗性KRASG12C抑制可有效驱动免疫原性肺癌中的干扰素介导的抗肿瘤免疫

Edurne Mugarza ,Febe van Maldegem ,Jesse Boumelha ,Christopher Moore ,Sareena Rana ,Miriam Llorian Sopena ,Philip East ,Rachel Ambler ,Panayiotis Anastasiou ,Pablo Romero-Clavijo ,Karishma Valand ,Megan Cole ,Miriam Molina-Arcas ,Julian Downward

Therapeutic KRASG12C inhibition drives effective interferon-mediated antitumor immunity in immunogenic lung cancers

治疗性KRASG12C抑制可有效驱动免疫原性肺癌中的干扰素介导的抗肿瘤免疫

Edurne Mugarza,Febe van Maldegem,Jesse Boumelha,Christopher Moore,Sareena Rana,Miriam Llorian Sopena,Philip East,Rachel Ambler,Panayiotis Anastasiou,Pablo Romero-Clavijo,Karishma Valand,Megan Cole,Miriam Molina-Arcas,Julian Downward